Sisaf Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sisaf Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10477
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSillic-RX, for gene therapy or oral delivery of large unstable peptides and proteins; ProSillic-OTC products, for cosmeceuticals or nutraceuticals. Sisaf’s platform technology uses elemental silicon particle to allow active compounds to penetrate into the deeper layers of the skin and finds application in the treatment of diseases such as skin melanoma, acne, psoriasis, scar, wound healing, cancer, diabetes, and Alzheimers disease, among others. The company provides formulation services; and licenses its technologies to clients in the life science industry. Its products are used in pharmaceutical, cosmetics, biotech, and lab technology sectors. Sisaf is headquartered in Belfast, the UK.

Sisaf Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sisaf Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sisaf Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sisaf Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sisaf Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Sisaf Raises USD4.3 Million in Venture Financing 10
SiSaf Raises USD3.5 Million in Series A Financing 11
SiSaf Raises USD0.6 Million in Venture Financing 12
SiSaf Raises USD0.8 Million in Venture Financing 13
Private Equity 14
SiSaf Plans to Raise Funds in Financing Round 14
Acquisition 15
Croda International Acquires Minority Stake in SiSaf 15
Sisaf Ltd – Key Competitors 16
Sisaf Ltd – Key Employees 17
Sisaf Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Sisaf Ltd, Medical Equipment, Key Facts 2
Sisaf Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sisaf Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sisaf Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Deals By Market, 2012 to YTD 2018 8
Sisaf Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sisaf Raises USD4.3 Million in Venture Financing 10
SiSaf Raises USD3.5 Million in Series A Financing 11
SiSaf Raises USD0.6 Million in Venture Financing 12
SiSaf Raises USD0.8 Million in Venture Financing 13
SiSaf Plans to Raise Funds in Financing Round 14
Croda International Acquires Minority Stake in SiSaf 15
Sisaf Ltd, Key Competitors 16
Sisaf Ltd, Key Employees 17
Sisaf Ltd, Other Locations 18
Sisaf Ltd, Subsidiaries 18

List of Figures
Sisaf Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sisaf Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sisaf Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sisaf Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sisaf Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sisaf Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sisaf Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Companhia Paranaense de Energia SA (CPLE6):企業の財務・戦略的SWOT分析
    Companhia Paranaense de Energia SA (CPLE6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Kin and Carta plc (KCT):企業の財務・戦略的SWOT分析
    Kin and Carta plc (KCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • Covalon Technologies Ltd (COV)-医療機器分野:企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinic …
  • VTB Bank:企業のM&A・事業提携・投資動向
    VTB Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VTB Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Votorantim Energia Ltda.:企業の戦略的SWOT分析
    Votorantim Energia Ltda. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • H. Lundbeck A/S:企業のM&A・事業提携・投資動向
    H. Lundbeck A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's H. Lundbeck A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Warburg Pincus LLC:戦略・SWOT・企業財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Daikin Industries, Ltd.:企業の戦略・SWOT・財務分析
    Daikin Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daikin Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Helsinn Healthcare SA:企業のM&A・事業提携・投資動向
    Helsinn Healthcare SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Helsinn Healthcare SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Showa Shell Sekiyu KK (5002):電力:M&Aディール及び事業提携情報
    Summary Showa Shell Sekiyu KK (Showa Shell) is an energy company. It mainly manufactures and sells oil products and energy related products, such as solar cell products and electricity. The company procures crude oil, refines, stores and sells petroleum products. Its product portfolio includes gasol …
  • Anthem, Inc.:企業の戦略・SWOT・財務情報
    Anthem, Inc. - Strategy, SWOT and Corporate Finance Report Summary Anthem, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Genting Berhad:企業の戦略・SWOT・財務情報
    Genting Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lung Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Therapeutics Inc (Lung Therapeutics) is a pharmaceutical company that offers orphan drug indications for lung injury and disease. The company provides service to underserved, life-threatening lung condition pursues an innovative treatment. Its pipeline candidates include LTI-01, single …
  • Pepticom Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pepticom Ltd (Pepticom) is a drug discovery and development company focused on novel peptide drug candidates. The company's artificial intelligence platform for peptide design models based on the target's solved crystal structure of the target protein. Its products includes copaxone, used fo …
  • Leonardo DRS Inc:企業の戦略的SWOT分析
    Leonardo DRS Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆